Industry Tells USPTO Biden March-In Proposal Undermines Inquiry to Improve IP Commercialization

“We are convinced such a mistaken reinterpretation of law is not legal, will not be effective in reducing drug pricing, and will actually significantly inhibit the very goals this RFC raises.” – AUTM comments Two days after comments closed on…








